Analgesics in Ukraine

September 2021 | 27 pages | ID: A9FA35716A0EN
Euromonitor International Ltd

Abstracts

Analgesics is expected to perform well in 2021, with value growth on par with 2020. COVID-19 is still influencing consumer behaviour as infection rates remain high for much of 2021. Aspirin is expected to register the highest current value growth. Aspirin is taken as an anti-thrombotic medicine and with COVID-19 known to causes blood clotting, aspirin was in high demand, along for its use as an analgesic. Adult acetaminophen is also expected to register strong current value growth, again driven...

Euromonitor International's Analgesics in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

ANALGESICS IN UKRAINE
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 still influencing consumer behaviour
Increasing price sensitivity
Leading players benefit from well-known brand names and strong advertisements
PROSPECTS AND OPPORTUNITIES
Growth returns to lower, normal levels over forecast period
Winners and losers over forecast period
Fierce battle between generics and branded over forecast period
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2016-2021
Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Analgesics: % Value 2017-2021
Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN UKRAINE
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Distribution of Consumer Health by Format: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format and Category: % Value 2021
Table 15 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources